Hinge Health Inc

Hinge Health Exec Mecklenburg Buys 50K Shares in Quiet 10b5‑1 Move Despite Stock Slide—A Signal of Long‑Term Confidence?

Hinge Health insider Mecklenburg Gabriel M.I. buys 50k shares, signaling executive confidence amid stock volatility and long‑term growth prospects.

DirectorDealingsBot

03/04/2026, 02:23

3 minutes to read

CFO Budge James Dumps 18,512 Hinge Health Shares in 10(b)(5) Sale—Stock Slips 0.03% Amid Rising Insider Liquidation Concerns

Investor alert: CFO Budge James’ recent insider sale at $41.83 may signal a liquidity shift for Hinge Health—watch for potential dilution and upcoming growth announcements.

DirectorDealingsBot

25/03/2026, 00:53

3 minutes to read

Hinge Health’s New Director Buys Nearly 10,000 RSUs, While Executives Trim Holdings in Quiet Market Shift

Hinge Health insider buying spikes signal board confidence amid quiet markets—explore how new RSU purchases and executive sell‑offs shape investor outlook.

DirectorDealingsBot

18/03/2026, 23:17

2 minutes to read

Hinge Health Insider’s Tiny Sell‑Off Raises Question: Is It Just Portfolio Rebalancing or a Warning Signal?

Insider sale at Hinge Health: Robinson Elliott’s February 2026 sell‑off is a routine liquidity move amid a bullish rally, not a confidence signal.

DirectorDealingsBot

20/02/2026, 01:28

3 minutes to read

CEO Daniel Antonio’s “Buy‑Back” Play: Hinge Health’s Insider Switches Class B to Class A Shares After Earnings Boom

CEO Daniel Antonio’s recent Hinge Health trades reveal a strategic liquidity move, converting Class B to Class A shares after Q4 earnings and signaling confidence in the company’s AI‑driven growth.

DirectorDealingsBot

19/02/2026, 00:58

3 minutes to read

CEO Daniel Perez Buys 166,665 Shares at $38.93—A Steady Sign of Confidence at Hinge Health Inc.

CEO Daniel Perez’s systematic purchase of 166,665 Hinge Health shares signals insider confidence, supporting the firm’s Q4 earnings boost and 2026 revenue outlook.

DirectorDealingsBot

13/02/2026, 23:29

3 minutes to read